Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Karim, Qumosani"'
Autor:
Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork M. Peltekian, Lusine Abrahamyan, Monika Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith Lindor, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, Maria-Carlota Londoño, Pier M. Battezzati, Albert Pares, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak J. Trivedi, Ana Lleo, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya F. Gulamhusein, Harry LA. Janssen, Aldo J. Montano-Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101168- (2024)
Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in disease and it is not known
Externí odkaz:
https://doaj.org/article/8d1c44ac78ae4a3ebc2eca8571c39ace
Autor:
Alan Gob, Mayur Brahmania, Anton Skaro, Yashasavi Sachar, Abdulrhman Alamr, Ephraim Tang, Anouar Teriaky, Karim Qumosani, Corinne Weernink, Melanie Dodds, Kelly Thomas, Lynne Sinclair
Publikováno v:
BMJ Open Quality, Vol 12, Iss 1 (2023)
Length of stay (LOS) is a significant contributor to overall patient outcomes for patients undergoing liver transplantation. This study documents a quality improvement project aiming to reduce the median post-transplant LOS for liver transplant patie
Externí odkaz:
https://doaj.org/article/adf77f316ba74a1ba3a676ce52c58d14
Autor:
Waleed Alghamdi, Khaled Lotfy, Corinne Weernink, Enad Alsolami, Anthony Jevnikar, Patrick Luke, Anton Skaro, Karim Qumosani, Mayur Brahmania, Paul Marotta, Syed M. Hosseini-Moghaddam, Anouar Teriaky
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Transplantation offers the best survival for patients with end stage organ disease. Transplant of hepatitis C virus (HCV) nucleic acid test (NAT) positive organs into negative recipients is a novel strategy that can expand the don
Externí odkaz:
https://doaj.org/article/1c6bd3c4d46748bdaf8a5446c1cc81da
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background IgG4-related disease involvement of the digestive tract is very rare. In few reported cases of isolated gastric/duodenal IgG4-related disease, none of which resulted in luminal obstruction. Case presentation A 59 years old female
Externí odkaz:
https://doaj.org/article/e65dd2dffdac4e06aa1bb2f3f69b77ed
Autor:
Mohammed Alsager, Shuet Fong Neong, Radhika Gandhi, Anouar Teriaky, Ephraim Tang, Anton Skaro, Karim Qumosani, Les Lilly, Zita Galvin, Nazia Selzner, Mamatha Pallavi Bhat, Klajdi Puka, Mayur Brahmania
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Liver transplantation (LT) remains the curative treatment for symptomatic Polycystic Liver Disease (PCLD) patients and is associated with excellent survival rates. The aim of the study is to review the Ontario experience in LT for
Externí odkaz:
https://doaj.org/article/ca85c0435b9a4223b531103084c01d7c
Publikováno v:
Clinical Case Reports, Vol 7, Iss 11, Pp 2135-2139 (2019)
Abstract Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory, and histological findings. Initial treatment involves cessation of infliximab and
Externí odkaz:
https://doaj.org/article/8c002a9151d54b2994a07fa4973ab74b
Autor:
Surain B, Roberts, Gideon M, Hirschfield, Lawrence J, Worobetz, Catherine, Vincent, Jennifer A, Flemming, Angela, Cheung, Karim, Qumosani, Mark, Swain, Dusanka, Grbic, Hin Hin, Ko, Kevork, Peltekian, Nazia, Selzner, Lusine, Abrahamyan, Bishoi, Aziz, Ellina, Lytvyak, Kattleya, Tirona, Aliya F, Gulamhusein, Harry L A, Janssen, Aldo J, Montano-Loza, Andrew L, Mason, Bettina E, Hansen
Publikováno v:
Hepatology. 76:303-316
We investigated associations between ethnicity, survival, and disease severity in a diverse Canadian cohort of patients with primary biliary cholangitis (PBC).Patients with PBC were included from the Canadian Network for Autoimmune Liver Disease. Eth
Autor:
Michael Sey, Sarah Cocco, Cassandra McDonald, Zaid Hindi, Hasibur Rahman, Debarati Chakraborty, Karissa French, Mohammed Alsager, Omar Siddiqi, Marc-Andre Blier, Bharat Markandey, Sarah Al Obaid, Anthony Wong, Victoria Siebring, Mayur Brahmania, Jamie Gregor, Nitin Khanna, Michael Ott, Karim Qumosani, Aze Wilson, Leonardo Guizzetti, Brian Yan, Vipul Jairath
Publikováno v:
JAMA network open. 5(8)
Trainees routinely participate in colonoscopy procedures, yet whether their involvement is positively or negatively associated with procedural quality is unknown because prior studies involved small number of trainees and/or supervisors, lacked gener
Autor:
Jeremy Parfitt, Salman Aziz, Karim Qumosani, Anton I. Skaro, Mayur Brahmania, Michael Sey, Paul Marotta, Anouar Teriaky, David K. Driman
Publikováno v:
Transplantation Proceedings. 53:1975-1979
BACKGROUND Recurrence of hepatocellular carcinoma (HCC) after liver transplantation is a major cause of morbidity and mortality. To date, there is no widely accepted pathologic assessment tool to predict HCC recurrence. In 2007, we developed a pathol
Autor:
Yashasavi Sachar, Abdulrhman Alamr, Alan Gob, Ephraim Tang, Anouar Teriaky, Karim Qumosani, Corinne Weernink, Melanie Dodds, Kelly Thomas, Lynne Sinclair, Anton Skaro, Mayur Brahmania
Publikováno v:
BMJ Open Quality. 12:e002149
Length of stay (LOS) is a significant contributor to overall patient outcomes for patients undergoing liver transplantation. This study documents a quality improvement project aiming to reduce the median post-transplant LOS for liver transplant patie